About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage Disease
By
Luis Raez
21 Videos
0 views
May 27, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Recommended
AUTOPLAY
ON
Related
Newest
08:49
David Carbone
The Use of IO Doublet in PD-L1-Negative NSCLC
35:40
Balazs Halmos
Year in Review: Lung Cancer
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
27:04
Fengting Yan
Cancer Screening Molecular Tools
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
36:14
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …
Feat.
B. Halmos
02:41
GRACE
Staging Disease: How Oncologists Stage NSCLC
Feat.
I. Dagogo-Jack,
M. Das,
C. Jeffrey Yang
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
14:49
Vivek Subbiah
Year in Review: Precision Medicine
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …
Feat.
E. Rodriguez
30:27
Insights from 2023 ESMO Annual Meeting
Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…
Feat.
G. Mountzios
19:33
ecancer
ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC
Feat.
E. Felip,
A. Spira,
A. Passaro,
A. Addeo
09:40
John Conibear
PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC
21:24
Chul Kim
ADCs and Bispecific Inhibitors in NSCLC
16:12
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
Feat.
R. Osarogiagbon
07:31
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…
Feat.
J. West
23:05
Fayez Kheir
Microwave Ablation for Malignant Airway Disease
